Shufeng Zhou

6.5k total citations · 2 hit papers
112 papers, 5.2k citations indexed

About

Shufeng Zhou is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Shufeng Zhou has authored 112 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 25 papers in Oncology and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Shufeng Zhou's work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (8 papers) and Cancer therapeutics and mechanisms (8 papers). Shufeng Zhou is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (8 papers) and Cancer therapeutics and mechanisms (8 papers). Shufeng Zhou collaborates with scholars based in China, Australia and Singapore. Shufeng Zhou's co-authors include Balram Chowbay, Junping Liu, Yihuai Gao, Eli Chan, Wei Duan, Min Huang, Xiaotian Li, Xihu Dai, Yong Li and Wenqi Jiang and has published in prestigious journals such as PLoS ONE, Development and Cancer Research.

In The Last Decade

Shufeng Zhou

110 papers receiving 5.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polymorphism of human cytochrome P450 enzymes and its clinical impact

2009 613 citations Shufeng Zhou, Junping Liu et al. profile →
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance

2009 597 citations Shufeng Zhou profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shufeng Zhou China	34	2.3k	1.2k	913	819	449	112	5.2k
Hong‐Hao Zhou China	49	3.6k 1.6×	1.7k 1.3×	1.4k 1.5×	833 1.0×	557 1.2×	258	7.8k
James W. Paxton New Zealand	35	1.7k 0.7×	859 0.7×	1.4k 1.5×	574 0.7×	817 1.8×	161	4.8k
Helmut K. Seitz Germany	55	2.4k 1.0×	865 0.7×	879 1.0×	423 0.5×	230 0.5×	226	9.6k
Jacques Magdalou France	43	3.0k 1.3×	2.0k 1.6×	1.2k 1.3×	857 1.0×	1.3k 2.9×	259	7.5k
Michinao Mizugaki Japan	37	2.5k 1.1×	1.0k 0.8×	447 0.5×	617 0.8×	317 0.7×	251	5.1k
Xiaochao Ma United States	38	1.8k 0.8×	1.6k 1.3×	1.2k 1.3×	287 0.4×	273 0.6×	138	4.9k
Raghvendra K. Dubey United States	48	1.7k 0.7×	522 0.4×	591 0.6×	345 0.4×	414 0.9×	148	7.0k
Young‐Nam Cha South Korea	38	2.5k 1.1×	675 0.5×	409 0.4×	346 0.4×	267 0.6×	100	4.6k
Christopher E. Goldring United Kingdom	43	3.8k 1.6×	1.5k 1.2×	743 0.8×	275 0.3×	222 0.5×	124	7.1k
Toshinori Yamamoto Japan	39	1.3k 0.6×	824 0.7×	1.1k 1.2×	399 0.5×	470 1.0×	183	4.2k

Countries citing papers authored by Shufeng Zhou

Since Specialization

Citations

This map shows the geographic impact of Shufeng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufeng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufeng Zhou more than expected).

Fields of papers citing papers by Shufeng Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shufeng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufeng Zhou. The network helps show where Shufeng Zhou may publish in the future.

Co-authorship network of co-authors of Shufeng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Shufeng Zhou. A scholar is included among the top collaborators of Shufeng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufeng Zhou. Shufeng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Shufeng, Meryem Blati, Kenneth W. Finnson, et al.. (2025). IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway. Experimental Hematology and Oncology. 14(1). 64–64.

Chen, Lichan, et al.. (2023). Modulation of afterglow electrochemiluminescence from nitrogen-deficient graphitic carbon nitride by pH. New Journal of Chemistry. 47(37). 17220–17223. 2 indexed citations

Zhong, Yuting, et al.. (2022). Functionalized Graphitic Carbon Nitride Nanomaterials for Electrochemiluminescent Detection of Cancer Cells. Journal of The Electrochemical Society. 169(11). 117507–117507. 2 indexed citations

Wang, Tao, Dongxi Xiang, Yin Wang, et al.. (2020). Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells. Scientific Reports. 10(1). 22191–22191. 3 indexed citations

Hu, Wei‐Wen, et al.. (2015). Advancement of Nucleic Acid Biosensors Based on Morpholino. American Journal of Biomedical Sciences. 40–51. 4 indexed citations

Wang, Tao, Michael P. Gantier, Dongxi Xiang, et al.. (2015). EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model. Theranostics. 5(12). 1456–1472. 87 indexed citations

Zhou, Shufeng, Rong Hu, Yu Xiong, et al.. (2014). Microarray analysis of differentially expressed genes in preeclamptic and normal placental tissues. Clinical and Experimental Obstetrics & Gynecology. 41(3). 261–271. 1 indexed citations

Xu, Jian, et al.. (2009). Combination of immunotherapy with anaerobic bacteria for immunogene therapy of solid tumours. Griffith Research Online (Griffith University, Queensland, Australia). 13(1). 36–52. 17 indexed citations

Wang, Linlin, Yong Li, & Shufeng Zhou. (2009). Prediction of deleterious non-synonymous single nucleotide polymorphisms of genes related to ethanol-induced toxicity. Toxicology Letters. 187(2). 99–114. 3 indexed citations

10.

Wu, Jun, Xiao Yang, Shufeng Zhou, et al.. (2009). Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells. Inflammation Research. 58(8). 473–482. 33 indexed citations

11.

Chen, Xiao, Junping Liu, Bee Jen Tan, et al.. (2008). The C-terminus of PRK2/PKNγ is required for optimal activation by RhoA in a GTP-dependent manner. Archives of Biochemistry and Biophysics. 479(2). 170–178. 9 indexed citations

12.

Chowbay, Balram, Brian C. Goh, Srinivasa Rao Jada, et al.. (2008). Influence of UGT1A9 intronic I399C4T polymorphism on SN-38 glucuronidation in Asian cancer patients. Faculty of Health; Institute of Health and Biomedical Innovation. 2 indexed citations

13.

Zhang, Weishi, Adam Smith, Junping Liu, et al.. (2008). GSK3β modulates PACAP-induced neuritogenesis in PC12 cells by acting downstream of Rap1 in a caveolae-dependent manner. Cellular Signalling. 21(2). 237–245. 21 indexed citations

14.

Zhong, Shilong, Shufeng Zhou, Xiaohong Chen, et al.. (2006). Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. European Journal of Pharmaceutical Sciences. 28(1-2). 77–85. 65 indexed citations

15.

Zhu, Yimin, et al.. (2005). The PKCα-D294G Mutant Found in Pituitary and Thyroid Tumors Fails to Transduce Extracellular Signals. Cancer Research. 65(11). 4520–4524. 23 indexed citations

16.

Gao, Yihuai, Wenbo Tang, Xihu Dai, et al.. (2005). Effects of Water-Soluble Ganoderma lucidum Polysaccharides on the Immune Functions of Patients with Advanced Lung Cancer. Journal of Medicinal Food. 8(2). 159–168. 64 indexed citations

17.

Tang, Wenbo, Yihuai Gao, Guoliang Chen, et al.. (2005). A Randomized, Double-Blind and Placebo-Controlled Study of a Ganoderma lucidum Polysaccharide Extract in Neurasthenia. Journal of Medicinal Food. 8(1). 53–58. 48 indexed citations

18.

Tian, Quan, Jing Zhang, Theresa May Chin Tan, et al.. (2005). Human Multidrug Resistance Associated Protein 4 Confers Resistance to Camptothecins. Pharmaceutical Research. 22(11). 1837–1853. 87 indexed citations

19.

Yang, Xiaoxia, Zeping Hu, Sui Yung Chan, et al.. (2005). Novel Agents that Potentially Inhibit Irinotecan-Induced Diarrhea. Current Medicinal Chemistry. 12(11). 1343–1358. 40 indexed citations

20.

Gao, Yihuai & Shufeng Zhou. (2003). Cancer Prevention and Treatment by Ganoderma , a Mushroom with Medicinal Properties. Food Reviews International. 19(3). 275–325. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact